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Available online 9 August 2013Fibromyalgia syndrome is a chronic pain disorder characterised by widespread pain and tenderness in muscles
and deep tissues. Current theories regarding the pathophysiological origins of ﬁbromyalgia syndrome point
towards central sensitisation and a decreased capacity of descending nociceptive controls. Morphological
alterations to subcortical brain regions may contribute to such pathophysiological mechanisms, and to pain
and other symptoms seen in ﬁbromyalgia. Therefore, we evaluated geometric differences in subcortical
structures in ﬁbromyalgia patients relative to healthy people using a novel method of shape analysis. Sixteen
female ﬁbromyalgia patients and 15 age and sex matched, healthy control subjects underwent high-
resolution T1-weighted magnetic resonance image scanning. Data was analysed using shape analysis of
15 subcortical regions and standard voxel-based morphometry analysis.
Fibromyalgia syndrome patients, relative to healthy control participants, exhibited alterations to the shape of
the left lateral aspect of the lower brainstem (medulla). The mean total volume of the brainstem was also
found to be signiﬁcantly reduced in the patient group compared to healthy control subjects, and this brainstem
volume reduction in patient group signiﬁcantly correlated with clinical manual tender point scale scores. Voxel-
based morphometry analysis revealed that patients also demonstrated decreased local grey matter volumes in
the brainstem (pons) and left precuneus, and increased greymatter volumes in bilateral primary somatosensory
cortices.
Results suggest that the volume reduction and associated geometric shape alterations seen in the brainstem of
the patient group may contribute to sensitivity to pressure pain in ﬁbromyalgia syndrome. This ﬁnding may be
due to structure-related deﬁciencies in regions subserving descending nociceptive control.
© 2013 The Authors. Published by Elsevier Inc.Open access under CC BY-NC-SA license. 1. Introduction
Fibromyalgia syndrome (FMS) is a chronic pain disorder characterised
by widespread pain and tenderness, morning stiffness, sleep distur-
bance and fatigue (Bennett et al., 2007;Wolfe et al., 1990). FMS patients
also demonstrate hyperalgesia and allodynia and cognitive deﬁcits
(Clauw, 2009) and dysfunctional postural control (Jones et al., 2011).
The disorder is often co-morbid with other diagnoses such as chronic
fatigue syndrome, temporomandibular joint disorder and irritableental Psychology, Institute of
uilding, Bedford Street South,
.Open access under CC BY-NC-SA licen
          bowel syndrome (Clauw, 2009). In 1990, the American College of
Rheumatology (ACR) empirically deﬁned FMS as pain during manual
palpation of at least 11 out of 18 designated tender points and affecting
all 4 quadrants of the body for a period of at least three months (Wolfe
et al., 1990). A more recent ACR criterion, without a need for a physical
examination, classiﬁes FMS patients according to widespread pain
index and symptom severity scores (Wolfe et al., 2010).
As alterations to central processing of somatosensory stimuli may
inﬂuence symptomsof FMS (Clauwet al., 2011), studies have previously
utilised voxel based morphometry (VBM) to investigate structural grey
matter differences in FMS patients relative to healthy control subjects
(Burgmer et al., 2009; Kuchinad et al., 2007; Luerding et al., 2008;
Lutz et al., 2008; Robinson et al., 2011; Schmidt-Wilcke et al., 2007;
Valet et al., 2009). FMS patients have demonstrated local grey matter
density reductions in cingulate, insular cortices, medial frontal cortices,
parahippocampal gyri (Kuchinad et al., 2007), superior temporal gyrus
and left posterior thalamus (Schmidt-Wilcke et al., 2007). Grey matterse. 
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lum and bilateral striatum (Schmidt-Wilcke et al., 2007). Analyses
excluding age and depression identiﬁed reduced grey matter volumes
in prefrontal, cingulate and insular cortices of FMS patients (Valet
et al., 2009), although an alternative study suggested that alterations
were negated when implementing depression as a covariant (Hsu
et al., 2009). VBM analyses of pre-deﬁned regions of interest of FMS
patients have shown reduced greymatter volumes in the cingulate, pre-
frontal and insular cortices, hippocampi and amygdala (Burgmer et al.,
2009; Lutz et al., 2008; Robinson et al., 2011).
Unfortunately, there is little consistency in the VBM data from FMS
studies. This may result frommethodological issues pertaining to tissue
classiﬁcation and arbitrary smoothing (Jones et al., 2005; Patenaude
et al., 2011; Smith et al., 2006). Factors such as age, sample size and
relative proportions of symptoms contributing to the complex symptom
proﬁle in the FMS population can also affect ﬁndings (May, 2011). VBM
has also been used to identify structural differences in patients with
irritable bowel syndrome (Seminowicz et al., 2010), tension type
headache (Schmidt-Wilcke et al., 2005), chronic fatigue syndrome
(de Lange et al., 2005) and post-traumatic stress disorder (Chen
et al., 2006; Villarreal et al., 2002). FMS is often comorbid with
these disorders, and the overlap of symptoms has led some researchers
to propose that similar neurophysiological mechanisms may be
involved (Ablin and Clauw, 2009; Phillips and Clauw, 2011; Williams
and Clauw, 2009). It is possible that a particularly high prevalence of a
speciﬁc comorbidity in a heterogeneous FMS population could
drive regional grey matter changes identiﬁed using VBM and explain
the wide variety in the data.
In the present study, shape analysis ofﬁfteen subcortical regionswas
carried out in a homogenous sample of female FMS patients and
healthy, age-matched control subjects. Thismethod can be used to com-
paratively investigate shape and volume of subcortical structures, and
has recently been used to investigate abnormalities in long term absti-
nent alcoholics (Sameti et al., 2011), patients with Alzheimer's disease
(Zarei et al., 2010) and age-related changes in healthy populations
(Goodro et al., 2012). This novel technique has been recently validated
and shown to be consistent over a variety of magnetic ﬁeld strengths
and acquisition systems (Goodro et al., 2012). Shape analysis can locate
subcortical structural boundaries without the need for smoothing.
Therefore, it can accurately identify both location and direction of com-
plexmorphological alterations through directmeasurement of geomet-
ric shape more precisely than VBM (Patenaude et al., 2011). In order
to compare results with shape analyses concurrent global and local
grey matter alterations throughout the whole brain of FMS patients
were also investigated using VBM. We hypothesised that FMS patients
would show subcortical abnormalities in shape and volume and that
the degree of such morphological changes would correlate with clinical
measures of FMS severity such as manual tender point scale (MTPS)
scores (Wolfe et al., 1990), Beck Depression Inventory (BDI) scores
(Beck et al., 1961) and Fibromyalgia Impact Questionnaire (FIQ) scores




Sixteen female patients (age 38.5 ± 8.45 years, mean ± SD) took
part in the study. Mean duration of symptoms was 9.1 ± 6.8 years,
and mean time since diagnosis was 2.8 ± 1.3 years (mean ± SD). All
patients fulﬁlled ACR criteria for diagnosis with ﬁbromyalgia on the
day of scanning (Wolfe et al., 1990). Patients were recruited from
two outpatient ﬁbromyalgia clinics at regional NHS Foundation
Trust hospitals; the Walton Centre, Liverpool, United Kingdom, and
Wirral University Teaching Hospital, Wirral, United Kingdom. Informed
consent was obtained from all participants in accordance with theDeclaration of Helsinki and the study was approved by the National
Research Ethics Committee of the United Kingdom, and the Research
Governance Committees of both hospitals. Patients aged between 22
and 52 years were considered for participation. Those with additional
disease or disorders (not commonly comorbid with FMS such as diabe-
tes or hypertension)were excluded, aswere patientswith a past history
of major disease, alcohol/drug abuse or serious head or brain injury.
Patients using analgesics (such as co-codamol) withdrew for 3
to 5 days prior to scanning. For example, a patient taking 6 to 8 tablets
of mild co-codamol (8/500 mg) a day was asked to discontinue
use for 3 days, a patient using up to 8 tablets of strong co-codamol
(30/500 mg), or high doses of dihydrocodeine, was asked to taper the
dose over a period of 2 days before discontinuing use for 3 days prior
to testing; withdrawalwasmanaged by the clinical team during consul-
tation. Analgesic medications with minimal central nervous system
effects, such as paracetamol, were permitted. Patients using medica-
tions with central nervous system effects (such as trycyclic antidepres-
sants), which were not deemed suitable for withdrawal by the clinical
team, were excluded. Common FMS medications at stable low doses
such as pregabalin (up to 75 mg twice a day), gabapentin (up to
300 mg twice a day) and amitriptyline (up to 10 mg at night), were
considered acceptable for the criteria ofminimal central nervous effects.
2.2. Controls
Fifteen age-matched female controls (age 39.4 ± 8.7 years,
mean ± SD) were recruited through campus advertisement. Volun-
teers taking regular medication, currently diagnosed with any disease
or disorder, or demonstrating a history of major disease, alcohol/drug
abuse or serious head or brain injury were excluded. All patients and
volunteers were compensated for time and travel expenses.
2.3. MRI data acquisition
High-resolution 3-dimensional T1-weighted images of the brain
were acquired using a whole-body Trio 3 T MRI imaging system
(Siemens, Erlangen Germany) and an 8-channel head coil. A T1
weighted modiﬁed driven equilibrium Fourier transform (MDEFT)
sequence (TR = 7.92 ms, TE = 2.48 ms, ﬂip angle = 16°, 176 sagittal
slices, slice thickness 1 mm, matrix 256 × 256, in-plane voxel size
1 mm × 1 mm, total acquisition time 12:51 min) was utilised. Fol-
lowing the MR scan all participants underwent a clinical MTPS exam-
ination (Wolfe et al., 1990), eighteen anatomically standard FMS tender
pointswere palpated for 4 s using the thumbpad of the dominant hand.
Pressure began at 1 kgf andwas incremented by 1 kg per second until a
maximum pressure of 4 kg is achieved. Following examination of each
point patients reported whether they felt any pain during palpation
and rated the pain verbally on a scale of 0 (no pain) to 10 (worst pain
ever experienced). All participants also completed the BDI and FIQ to
evaluate affective disturbance and the impact of symptoms on quality
of life in the week preceding the scan. Questionnaires and MTPS exam-
inations were administered immediately following the MR scanning
session (on the same day), so as to reﬂect medication levels and symp-
toms appropriate to the time of scanning.
2.4. Subcortical segmentation, vertex and volumetric analysis
Fifteen subcortical structures (brainstem, bilateral thalami, hippo-
campi, amygdalae, putamen, caudate nucleus, accumbens nucleus
and pallidum) were segmented from each subject's high-resolution
T1 structural scan using the Oxford Centre for Functional MRI of the
Brain's (FMRIB) integrated registration and segmentation tool (FIRST)
toolbox (Patenaude et al., 2011) in the FMRIB software library [FSL,
http://www.fmrib.ox.ac.uk/fsl, (Smith et al., 2004)]. Thismethod imple-
ments a probabilistic adaptation of the active appearance model using
a large, manually labelled data set as a training template wherein the
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established vertices. In an automated process, the images are linearly
registered (12 degrees of freedom) to the training template and subse-
quently to a standard Montreal Neurological Institute (MNI) space sub-
cortical mask template in FSL. Finally, shape and intensity variations in
the images are used to automatically segment structures in native
space using the inverse transformation.
To evaluate group differences in the shape of subcortical structures
vertex analysis was performed. Amultivariate Gaussianmodel of vertex
location and intensity variation was used to generate a surface mesh for
each structure in each subject. The number and correspondence ofmesh
vertices remain constant across subjects to allow for point-to-point
group comparisons of mean vertex positions. Corresponding vertices
of surface meshes for each individual subject were compared in stan-
dard MNI space using the Multivariate General Linear Model with
Pillai's trace as the test statistic. This results in a multivariate F-statistic
for each vertexwhich is sensitive to between groupdifferences in vertex
coordinates in any direction (Patenaude et al., 2011). Geometric shape
analysis of subcortical structures may be preferable to VBM for identiﬁ-
cation of subtle morphological alterations as this method identiﬁes the
location and direction of complex morphological alterations through
direct measurement of shape without the need for smoothing
(Patenaude et al., 2011). The accuracy of this method has been shown
to be superior to previous automated segmentation tools (Patenaude
et al., 2011), and FIRST analysis is consistent over a variety of magnetic
ﬁeld strengths and acquisition systems (Goodro et al., 2012). Thismethod
has also been compared to the ‘gold standard’ of segmentation in struc-
tural imaging,manual segmentation of images by an expert, and theﬁnd-
ings indicate a high degree of accuracy (Babalola et al., 2009). Individual
vertex results were corrected for multiple comparisons (across vertices)
using false discovery rate (FDR) method (Benjamini and Hochberg,
1995) and P b 0.05 was considered signiﬁcant. Bonferroni–Šidák correc-
tionwas also employed to account for themultiple comparisons required
across 15 structures.
As recent studies pointed to an association between Chiari I malfor-
mation and FMS (Heffez, 2011; Thimineur et al., 2002; Watson et al.,
2011), each anatomical image was assessed for Chiari I malformation
by measuring the distance from the inferior tip of the cerebellar tonsils
to the line connecting basion and opisthion (Watson et al., 2011). This
measure was of importance for evaluation of potential shape or volume
differences because increased pressure of cerebrovascular ﬂuid below
foramen magnum in Chiari I malformation may affect the shape of
subcortical structures such as the brainstem.
For structures demonstrating a signiﬁcant shape alteration in FMSpa-
tients relative to healthy participants, multivariate analysis of covariance
(MANCOVA) was performed using clinical and psychological measures
as covariates to investigate whether clinical or psychological variables
would explain group shape differences. However, if the measures
violated the assumption of homogeneity of regression slopes (i.e. dem-
onstrated a bimodal distribution which was conﬁrmed by a signiﬁcant
difference in group means using an independent samples t-test), then
they were deemed unsuitable for use in MANCOVA analysis. Instead,
these measures were implemented in a correlation analysis using FIRST
in the FMS patient group only. These variables were independently
entered as correlates in the design and vertex analysis was performed
to evaluate whether they correlated with vertex positions in structures
showing signiﬁcant group differences in shape. FDR correction was
applied to correct for multiple tests across vertices. Chiari I parameters,
MTPS scores, FIQ scores, BDI scores and individual brain structure vol-
umes were the measures utilised as potential confounds in MANCOVA
or correlation analyses to investigate signiﬁcant group differences.
The surface meshes generated for each subject were then
transformed back into native space and boundary corrected before
the volume (mm3) for each structure was calculated. For each subcorti-
cal structure demonstrating a signiﬁcant difference in shape analysis,
volumetric data were exported for each participant and mean valuesfor FMS patient group and healthy control group were compared using
Student's independent sample t-tests. In the event of signiﬁcant group
differences in the volume of speciﬁc structures, univariate ANCOVA was
performed implementing total intracranial volumes and total grey mat-
ter volumes from VBM analyses as covariates to evaluate whether such
factors would account for the ﬁndings. Individual volumes in the FMS
patient group were also utilised for Pearson's correlation analyses with
clinical measures (MTPS scores) in SPSS v.19 (SPSS Inc., Chicago, USA).
2.5. Voxel based morphometry analysis
VBM pre-processing and analysis were performed using VBM8 tool-
box (http://dbm.neuro.uni-jena.de/vbm) in SPM8 (Welcome Trust Cen-
tre for Neuroimaging, University College London, United Kingdom)
in Matlab v.7.8 (The MathWorks Inc., USA). Voxel based morphometry
consists of several steps including spatial normalisation of images, seg-
mentation of grey matter and other tissues, and analysis of global and
local differences in voxel intensities. Images were registered to MNI
space and an optimized method of VBM using the VBM8 Toolbox was
implemented for segmentation of grey and white matter, default set-
tings were used unless otherwise indicated. A hidden Markov random
ﬁeld model is applied as part of this procedure to reduce noise effects
and, as spatial normalisation causes expansion or contraction of some
brain regions, segmented images were scaled by the degree of contrac-
tion (modulated), so that the total volume of grey orwhitematter in the
images remains the same as in the original images. Images were
smoothed using an isotropic Gaussian kernel of 10 mm full width at
half maximum. A data quality check based on inhomogeneity measures
of the sample, as implemented in VBM8 toolbox, was used to check for
anomalous data (outside 2 standard deviations) which was visually
inspected and subsequently excluded if necessary. Using these criteria
no data was excluded from the sample.
A voxel-wise comparison was performed between the FMS patient
and healthy control group using the general linear model implemented
in VBM8. As in previous clinical studies (Buckalew et al., 2008; Schmidt-
Wilcke et al., 2006) where pain-related grey matter alterations may be
small, whole brain differences in voxel intensities were ﬁrst evaluated
using an initial threshold of P b 0.001 (uncorrected) to identify clusters
of contiguous voxels (thresholded to encompass at least 30 voxels)
showing a difference. Subsequently, the clusters of voxels demon-
strating grey matter volume differences at the uncorrected level were
compared using a statistical threshold corrected for family-wise error
(FWE) at cluster level (P b 0.05 corrected). Finally, for any regions
demonstrating signiﬁcant group differences, individual regional grey
matter volumes in the FMS patient group were exported and utilised
for Pearson's correlation analysis with MTPS, FIQ and BDI scores in
SPSS v.19. This analysis was performed to evaluate whether clinical or
psychological factors would account for alterations to regional grey
matter volumes in the FMS group.
2.6. Total intracranial tissue volumes and correlationswith clinicalmeasures
Total volumes of grey matter, white matter and total intracranial
volumes for each participant were exported and mean values for
FMS patient group and healthy control groups were compared using
Student's independent sample t-tests. Pearson's correlation analysis
was performed to evaluate possible correlations between total grey
matter volumes in the patient group and clinical measures of symptom
severity (MTPS, BDI and FIQ scores).
3. Results
3.1. Clinical and psychological analysis
A Student's independent t-test indicated a signiﬁcant difference be-
tween the mean MTPS scores for patients (4.98 ± 1.89) and controls
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tient group (63.37 ± 15.83) also differed signiﬁcantly from those in the
healthy control participants (6.26 ± 6.51); t (29) = 12.74, P b 0.001. A
signiﬁcant difference was also seen between mean BDI scores for FMS
patients (19.50 ± 11.19) and controls (3.87 ± 4.42); t (29) = 5.05,
P b 0.001.3.2. Shape analysis
Vertex analysis was performed to evaluate the shape and volume of
15 subcortical structures in FMS and healthy control groups. However,
only the brainstem showed a localised shape difference, which is signif-
icant following FDR correction for the number of vertices tested and
Bonferroni–Šidák correction for multiple comparisons across structures
(P = 0.01corr). In the FMSpatient group thebrainstemdemonstrated an
inward movement of vertices compared to healthy control participants
on the left lateral medullary funiculus extending from the inferior tip of
the brainstem to the level of the inferior olivary body (Naidich and
Duvernoy, 2009) suggesting a volume reduction in this region. A signif-
icant outwardmovement of fewer vertices located above this area in the
left medulla at the level of the inferior olivary body was also apparent
which further suggests an alteration to geometric shape in the region.
Taken together these results suggest an inward shape change to the
left lateral aspect of the brainstem in FMS patients at the level of theme-
dulla accompanied by a smaller (in size) outward shape change at the
level of the inferior olivary body. Fig. 1 shows the locations, directionsFig. 1. Vertex analysis of shape alterations in the brainstem of the FMS patient group in
comparison to healthy control participants. Upper panel shows the anatomical location
of the brainstem and the local area exhibiting shape change in FMS patient group. Lower
left panel indicates shape change in FMS patient group compared to healthy control
group at an uncorrected level, this transparent image shows direction of vectors, inward
direction represents relative inward positions of vertices (in FMS subjects compared
with healthy control subjects) indicative of volume reduction. Outward direction of
vectors indicates relative shape increases in FMS patient group. Arrow colour and surface
colour indicate the F-statistic of the change in the speciﬁc vertices (see colour bar). Lower
centre panel shows the location of the difference in patient group following FDR correction,
red colour indicates areas which did not differ signiﬁcantly from healthy control group.
Lower right panel shows a semi-transparent image following FDR correction, indicating
the direction of signiﬁcant vectors showing alterations in the FMS group in comparison
to healthy control participants.and F-statistics of shape change of brainstem vertices in the FMS
group relative to healthy control group.
A Student's independent t-test was performed to compare mean
brainstem volumes, as indicated by FIRST analysis, in FMS patient and
healthy control groups. The mean total volume of the brainstem in
FMS patient groupwas shown to be signiﬁcantly reduced in comparison
to healthy control participants (t (29) = 2.56, P = 0.016). Fig. 2A
shows the bar charts and error bars for both group's mean brainstem
volumes. Univariate ANCOVA analysis revealed that the group differ-
ence in volume of the brainstem was similarly signiﬁcant following
correction for total intracranial volume and total grey matter volume
covariates (F(1,27) = 7.30, P = 0.012). Pearson's correlation analysis
was performed to evaluate the relationship between the reduction of
brainstem volume and MTPS scores, BDI scores and FIQ scores in the
FMS patient group. A signiﬁcant one-tailed correlation (r = −0.45,
N = 16, P = 0.039) was evident, indicating that patients exhibiting
greater reductions in volume of the brainstem reported higher scores
for the MTPS evaluation. Fig. 2B shows the scatter plot of individual
brainstem volume and MTPS score data for the FMS patient group dis-
tributed along the regression line.
As Chiari I malformation might contribute to the shape and volume
changes in the brainstem, we analysed the distance between the
basion–opisthion line and lower tip of cerebellar tonsils (Watson
et al., 2011). Two FMS patients and one control subject showed a tonsil-
lar position N5 mm below the basion–opisthion line which meets theFig. 2. A: Bar chart illustrating the mean total volume of the brainstem in FMS patient
group and healthy control participants and error bars. * indicates a signiﬁcant difference
in an independent Student's t-test comparison of group mean values. B: Scatter plot
showing manual tender point scale (MTPS) scores and total volume of the brainstem
(mm3) as calculated during FIRST analyses. The linear regression line is also shown.
Table 1
Local greymatter volume decreases in FMSpatient group relative to healthy control group.
Structure MNI [mm] k Z T Sig.
x y z
Brainstem −14 −21 −38 35 3.41 3.82 0.008
Precuneus −23 −51 12 40 3.37 3.77 0.008
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tween the basion–opisthion line to the tip of cerebellar tonsils was
0.58 ± 3.33 mm (mean ± SD) in FMS group and −0.12 ± 2.23 mm
(mean ± SD) in healthy control subjects (t (29) = −0.68, P N 0.05),
positive values denotingmeasurements inferior to the basion–opisthion
line. This distance measurement was entered as a covariate in a
MANCOVA design vertex analysis in FIRST. The vertices differentiating
FMS patients and controls in the lower brainstem (Fig. 1A) remained
unchanged after entering the distance between basion–opisthion line
and the lower tip of cerebellar tonsils as a covariate. Thus, it is unlikely
that Chiari I malformation would account for the reduction of lower
brainstem volume seen in FMS patients. The additional clinical and psy-
chological data collected during the study demonstrated a signiﬁcant
bimodal distribution and was therefore not appropriate for MANCOVA
analysis. These variables (MTPS scores, BDI scores, FIQ scores and indi-
vidual brainstem volumes) were independently employed in correla-
tion analysis using FIRST in the FMS patient group. No signiﬁcant
correlations were identiﬁed between vertex positions in the brainstem
and any of the clinical or psychological measures in the FMS patient
group.
3.3. Regional grey matter volumes
Voxel-wise comparison of local grey matter volumes across the
whole brain revealed that FMS patients, relative to healthy control par-
ticipants, exhibited two signiﬁcant clusters of grey matter volume
reduction. One was located in the brainstem in the left ventral aspect
of the basilar pons, in the pontine nuclei, and the other in the left
precuneus (cluster extent P b 0.05, FWE-corrected). FMS patients alsoFig. 3. A: Local greymatter volume decreases as indicated by clusters representing spatial-
ly extended groups of voxels which differed signiﬁcantly in grey matter volume at the
uncorrected level (P b 0.001) in whole brain analysis and corrected level (P b 0.05) in
cluster level analysis. Clusters are displayed in glass brains (upper panel) and MNI
standardised anatomical brains (lower panel) x, y and z co-ordinates indicate slice dimen-
sions in MNI space. B: Local grey matter volume increases at the same signiﬁcance level.
Clusters are displayed in glass brains (upper panel) and MNI standardised anatomical
brains (lower panel).exhibited two clusters of grey matter volume increases located in
bilateral primary somatosensory cortices. Fig. 3 shows the locations of
clusters of voxels demonstrating grey matter alterations in FMS patient
group relative to healthy control subjects displayed in glass brains
and MNI standardised anatomical brains. Table 1 shows the MNI co-
ordinates of clusters demonstrating grey matter volume decreases.
Table 2 shows increases in FMS patients relative to healthy control sub-
jects. The anatomical locations of t-maxima as deﬁned by the Harvard–
Oxford atlas in FSL, peak T and Z values, number of voxels (k) and
the cluster-level FWE corrected signiﬁcance values are also shown.
Pearson's correlation analysis was used to investigate potential linear
relationships between regional grey matter volume changes and
MTPS, BDI and FIQ scores within the FMS patient group. Grey matter
volume data was extracted for all clusters demonstrating increases or
decreases for each patient in the FMS group and Pearson's correlations
with MTPS scores, BDI scores and FIQ scores were calculated. No signif-
icant correlations were found.
3.4. Total intracranial volume statistics and correlations with clinical
measures
A Student's independent samples t-test indicated no signiﬁcant dif-
ferences in mean total grey matter volume for FMS patients compared
to healthy control subjects (P N 0.05), although total mean grey matter
volume in FMSpatient group (626.30 cm3)was lower than in the healthy
control group (644.19 cm3). Pearson's correlation analysis showed a
signiﬁcant correlation between total grey matter volume and MTPS
scores in the FMS patient group (r = −0.63, N = 16, P = 0.009).
Patients with lower total grey matter volumes scored higher on the
MTPS examination. Fig. 4 shows the data distributed along the regression
line in a linear relationship. No correlations were seen between total
intracranial tissue volumes and regional grey matter changes.
4. Discussion
Analysis of subcortical structures revealed signiﬁcant differences in
the shape and volume of the brainstem of FMS patients. Voxel based
morphometry analysis also demonstrated local grey matter reductions
in the brainstem as well as in the left precuneus of FMS patients. The
volume reduction of the brainstem of FMS patients showed a signiﬁcant
correlation with MTPS scores, indicating that this structure may play an
important role in the pathogenesis or maintenance of deep tissue pain
and hyperalgesia in FMS. In addition, total grey matter volume in FMS
patients also demonstrated a negative correlation with MTPS scores
which further suggests that grey matter reductions in FMS are relevant
to symptom severity.Table 2
Local greymatter volume increases in FMS patient group relative to healthy control group.
Structure MNI [mm] k Z T Sig.
x y z
Left SI −36 −47 69 39 3.41 3.83 0.005
Right SI 39 −39 59 35 3.37 3.76 0.005
Anatomical structure location as deﬁned by the Harvard–Oxford atlas, t-maxima locations
according with MNI x, y, z coordinates in millimetres. L, left; R, right; k, number of voxels;
T, peak t values; Z, peak z values; Sig., cluster-level FWE corrected P values; SI, primary
somatosensory cortex.
Fig. 4. Scatter plot of manual tender point scale (MTPS) scores and total grey matter
volume (voxels) as indicated by VBM8 analyses in the FMS patient group. The linear re-
gression line is also shown.
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evident, located in the left lateral medullary funiculus extending from
the inferior tip of the medulla to the level of the inferior olivary body.
Patients also exhibited signiﬁcant reductions in mean total volume
of the brainstem. The uncorrected results (Fig. 1) show that similar
patterns of vertex alterations were seen bilaterally in the FMS patient
group at the level of the medulla. However, only left sided vertex alter-
ationswere evident following FDR correction in FIRST. Further investiga-
tion, utilising a larger patient group, is needed to investigate whether
alterations in the brainstem of FMS patients could actually occur bilater-
ally. Alternatively, unilateral shape alterations may be sufﬁcient to
cause widespread symptoms. Small unilateral brainstem infarction has
been shown to induce major cognitive problems (Garrard et al., 2002;
Hoffmann and Cases, 2008), andunilateral stimulation of periventricular
grey can relieve lower back pain (Rasche et al., 2006). Brainstem struc-
tures likely play an important role in the maintenance of central sensiti-
sation in FMS (Graven-Nielsen and Arendt-Nielsen, 2010; Petersel et al.,
2011), and it is possible that even unilateral structural alterations could
be sufﬁcient to contribute to development of widespread central sensiti-
sation. As no correlation was seen between brainstem vertex positions
and brainstem volume in the FMS patient group following FDR correc-
tion, it is not possible to infer that shape alterations in the brainstem of
FMS patients were directly related to volumetric reductions. However,
this lack of correlation may be due to the sample size, and this relation-
ship alsowarrants further investigationwith a larger FMSpatient cohort.
The inward shape alterations evident on the surface of the medulla
in FMS patients indicate a possible reduction in the nuclei underlying
this region. Speciﬁcally, a reduction in the volumeof the reticular forma-
tion nuclei could lead to the shape alterations seen on the brainstem
surface. Reticular formation nuclei are involved in many systems
which demonstrate dysfunction in FMS such as homeostatic regulation,
postural control and sleep cycle control (Naidich and Duvernoy, 2009).
This formation also contains the rostral ventromedial medulla which is
the major relay point between periaqueductal grey and dorsal horn
neurons, and the pathway of these three structures constitutes the pri-
mary descending pain modulation pathway in the brain (Lovick, 2008;
Naidich and Duvernoy, 2009). The nucleus raphe magnus, a group of
nuclei which also receive afferent input from the periaqueductal grey
and have efferent connections with dorsal horn neurons, is also located
in the region, and this structure is also important for descending pain
modulation.
Previous studies have demonstrated that descending pain modula-
tion is impaired in FMS (Julien et al., 2005; Kosek and Hansson, 1997).Functional MRI studies of FMS patients undergoing noxious stimulation
indicate reduced activity in regions of the brainstem associatedwith de-
scending pain inhibitory mechanisms (Jensen et al., 2009), and reduced
connectivity between the brainstem and pain processing regions
(Jensen et al., 2012). A VBM study also recently reported grey matter
reductions in the brainstem of chronic pain patients, including FMS
patients (May, 2009). Functional imaging of the brainstem and spinal
cord during innocuous and painful touch suggests that dysfunctional
descending pain modulation may be important in the experience
of allodynia pain (Ghazni et al., 2010), and such dysfunction may facili-
tate the development of chronic pain in FMS and other chronic pain
disorders (Staud, 2011a). In healthy participants, selected regions of
brainstem showed activation increases during stimulation of a second-
ary hyperalgesic area of skin (Zambreanu et al., 2005), and a role of
brainstem areas has also been suggested for anticipatory mechanisms
involved in the maintenance of chronic pain (Fairhurst et al., 2007).
Shape alterations and volumetric reductions in the brainstem may
relate to dysfunctional pain modulation in FMS. However, a recent
VBM study of chronic fatigue syndrome, a disorder closely related to
FMS, also suggests structural grey matter reductions in the brainstem
(Barnden et al., 2011) (although these changes appear to involve dif-
ferent sub-regions of brainstem).
In a complex syndrome such as FMS it is difﬁcult to surmise speciﬁc
clinical implications of local abnormalities from a cross-sectional study
as extraneous factors could also inﬂuence structural changes. FMS pa-
tients do less exercise and exhibit higher levels of obesity than healthy
people (Mork et al., 2010), and both of these factors were previously
shown to inﬂuence regional and total brain volumes in normal popula-
tions (Colcombe et al., 2006; Erickson et al., 2009). Duration of medica-
tion use was also previously shown to correlate with speciﬁc structural
alterations in FMS patients (Burgmer et al., 2009). Therefore, whilst
every effort was made to recruit a homogenous group of FMS patients,
it is impossible to ensure that the presence of FMS was the only factor
inﬂuencing brain structure alterations. However, as the shape and
volume alterations seen in the brainstem of patients did not correlate
with BDI or FIQ scores, we infer that changes to this structure in FMS pa-
tients do not relate to changes in mood associated with the disorder.
Shape changes in the lower brainstem of FMS patients cannot be at-
tributed to Chiari I malformation which may be associated with FMS,
or at least with a subgroup of patients (Heffez, 2011; Thimineur
et al., 2002;Watson et al., 2011). However, we cannot exclude the pos-
sibility that a combination of multiple anatomical factors in the
cervico-spinal region might have contributed to the shape change
seen in lower brainstem of FMS patients in the present study.
UsingVBManalysis, decreased local greymatter volumeswere iden-
tiﬁed in the brainstem of FMS patients located in the left ventral aspect
of the basilar pons. This region does not correspond to the difference
seen using shape analysis, but contains the pontine nuclei (Naidich
and Duvernoy, 2009) which are involved in the control and regulation
of motor activity. As FMS affects dynamic balance control and is associ-
ated with clumsiness and a high prevalence of falls (Jones et al., 2011),
grey matter reductions in this region could relate to reported dysfunc-
tional postural control. The left precuneus also demonstrated local
grey matter reductions in FMS patients relative to healthy control sub-
jects. Precuneus is an important structure in endogenous pain modula-
tion which demonstrates increased connectivity with periaqueductal
grey and posterior cingulate cortex during experimental pain relief
(Zyloney et al., 2010), and it is also a known structure of the default
mode network (Greicius et al., 2003)which can bedisrupted by ongoing
chronic pain (Baliki et al., 2008), and speciﬁcally FMS (Napadow et al.,
2010, 2012). Thus, grey matter reductions seen in the precuneus of
FMS patients may contribute to dysfunctional descending painmodula-
tion generated in the posteromedial cortex of FMS patients, or to disrup-
tion of the default mode network.
FMS patients exhibited bilateral increases in grey matter of somato-
sensory cortices. Primary somatosensory cortices are important in the
169N. Fallon et al. / NeuroImage: Clinical 3 (2013) 163–170discriminative aspects of pain processing (Lee et al., 2008), and aug-
mented activations were previously seen in somatosensory cortices
of ﬁbromyalgia patients during noxious pressure stimulation (Gracely
et al., 2002), and brushing of the forearm (Fallon et al., 2013).
Neuroplastic alterations in greymatter of chronic pain patients could re-
late to underlying mechanisms of central sensitisation (Woolf, 2011),
and dynamic re-organisation of neural networks may occur as tonic
pain persists in FMS (Staud, 2011b). A longitudinal study of chronic
pain patients with severe osteoarthritis undergoing hip arthroplasty
has shown that grey matter alterations normalise post-operatively
with pain reduction (Gwilym et al., 2010), and volume increases in pri-
mary somatosensory cortexmay ensue in healthy people after just eight
days of noxious stimulation lasting for only 20 min (Teutsch et al.,
2008). Therefore, greymatter increases in somatosensory regions of pa-
tients may represent dynamic changes related to impaired sensory pro-
cessing and discrimination in FMS. However, as experimental pain does
not accurately reﬂect the experience of ongoing chronic pain and, due to
the present uncertainty regarding the precise contribution of peripheral
afferent input to FMS pain, the cause of these alterations in FMS patients
requires further study.
Subcortical morphological alterations in FMS patients are pertinent
to the disorders pathophysiology and merit further investigation. The
novel technique of shape analysis used in the present study indicates
morphological abnormalities in structures relevant to endogenous
pain modulation and a variety of FMS symptoms. Vertex analysis in
FIRST is limited to the location of shape changes on the surface of each
structure, and volume analyses only reveal global volume differences
for each structure. However, as brainstem volume reductions correlated
with MTPS scores in the FMS patient group, structural alterations in the
present study may corroborate previous evidence for dysfunctional de-
scending inhibition in brainstem of FMS patients (Jensen et al., 2009,
2012). Therefore, the ﬁndings represent a step towards understanding
the structural underpinning for physiological mechanisms of FMS pain.
In future, high-resolution imaging studies should prioritise struc-
tural analysis of cervico-spinal region in FMS patients. Ultra high-
resolution T1-weighted MR scanning has already been utilised to iden-
tify nuclei and white matter tracts in the brainstem of ex vivo humans
(Soria et al., 2011), and future technical improvements may eventually
allow for in vivo evaluation of brainstem cytoarchitecture in FMS pa-
tients. Future studies could also further investigate whether subcortical
shape differences in FMS patients could correlate with functional ab-
normalities such as decreased functioning of descending nociceptive
control systems during experimental pain, dysfunctional postural con-
trol or sleep disturbance. Possible structural and functional alterations
to the pain modulatory system in FMS may also be affected by current
treatments (such as pharmacological interventions, self-management
programmes, or non-invasive brain stimulation techniques), and a
longitudinal investigation could improve understanding of both the
pathophysiology of FMS and the mechanisms of such interventions.
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